SFC Myissha Tompkins

Myissha N. Tompkins serves as a procurement professional responsible for managing complex acquisitions within the health services and medical technology sectors. Though her formal title and agency are not specified, her contracting patterns reveal a central role in advancing mission-critical health infrastructure through strategic sourcing. She routinely handles competitive and set-aside procurements for diagnostic equipment, laboratory services, and clinical support systems, ensuring alignment with federal acquisition regulations and operational readiness goals. Her work supports the acquisition lifecycle from requirements definition through contract award and administration, with a focus on delivering high-value, compliant solutions to public health objectives. Tompkins maintains a broad network of vendor relationships across medical technology manufacturers, diagnostic service providers, and health care support contractors. While specific contractor names are not identifiable, her procurement activity reflects consistent engagement with both large-scale suppliers of electromedical devices and specialized small businesses offering in-vitro diagnostic substances and imaging center services. Her contracting approach emphasizes competition, performance-based outcomes, and vendor accountability, fostering partnerships that balance innovation with regulatory compliance. Her procurement portfolio demonstrates a strong inclination toward open competition, with 76.2% of awards issued without set-aside restrictions. However, she actively supports small business participation, allocating 19.1% of contracts to Total Small Business Set-Asides under FAR 19.5 and 4.8% to 8(a) competed programs. This balanced approach reflects a deliberate commitment to socioeconomic goals without compromising market competitiveness or mission needs. Tompkins specializes in NAICS codes 811219 (medical and diagnostic laboratories), 325413 (in-vitro diagnostic substance manufacturing), and 621512 (diagnostic imaging centers), indicating deep expertise in clinical diagnostics and medical device procurement. She regularly acquires laboratory testing systems, diagnostic reagents, imaging equipment, and related technical services, demonstrating technical fluency in healthcare compliance, FDA-regulated products, and clinical workflow integration. Her domain knowledge ensures acquisitions align with evolving public health standards and technological advancements in diagnostic medicine.